Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain

J Neurochem. 1995 Oct;65(4):1658-64. doi: 10.1046/j.1471-4159.1995.65041658.x.

Abstract

Glycated residues of tau protein from paired helical filaments isolated from the brains of Alzheimer's disease patients were localized by doing a proteolytic cleavage of the protein, fractionation of the resulting peptides, and identification of those peptides using specific antibodies. The most suitable residues for glycation, lysines, present at the tubulin-binding motif of tau protein, seem to be preferentially modified compared with those lysines present at other regions. Among these modified lysines, those located in the sequence comprising residues 318-336 (in the largest human tau isoform) were found to be glycated, as determined by the reaction with an antibody that recognizes a glycated peptide containing this sequence. Because those lysines are present in a tubulin binding motif of tau protein, its modification could result in a decrease in the interaction of tau with tubulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amino Acid Sequence
  • Animals
  • Cattle
  • Glycosylation
  • Humans
  • Peptide Fragments / metabolism
  • Serine Endopeptidases / metabolism
  • Tubulin / metabolism*
  • tau Proteins / chemistry
  • tau Proteins / metabolism*

Substances

  • Peptide Fragments
  • Tubulin
  • tau Proteins
  • Serine Endopeptidases
  • glutamyl endopeptidase